2012_Poster_Abstracts by tangshuming

VIEWS: 78 PAGES: 9

									IMPORTANT ITEMS TO REMEMBER:
               Assigned
                Poster
    Name       Number                                         Title of Abstract
                            ALEMTUZUMAB FOR STEROID REFRACTORY ACUTE GRAFT VERSUS HOST DISEASE IN PEDIATRIC
Pooja Khandelwal        500 PATIENTS PEDIATRIC PATIENTS: A RETROSPECTIVE REVIEW
Saroj Purohit           501 GENERATION OF INDUCIBLE REGULATORY T CELLS IS ENHANCED BY 5-AZACYTIDINE.
                            RENDERING NATURAL KILLER CELLS RESISTANT TO TRANSFORMING FACTOR-β (TGF-β) TO IMPROVE
Mohamed Abdel-Baki      502 ANTITUMOR ACTIVITY
                            MULTI-INSTITUITIONAL STUDY OF CHEMOTHERAPY-ONLY PREPARATIVE REGIMEN (WITHOUT
                            RADIATION) FOR ALTERNATIVE DONOR HEAMTOPOIETIC STEM CELL TRANSPLANTATION FOR
Parinda Mehta           503 PATIENTS WITH FANCONI ANEMIA, AN INTERIM REPORT
                            HIGH DOSE METHYLPREDNISOLONE FOR VENO-OCCLUSIVE DISEASE OF THE LIVER IN PEDIATRIC
Kasiani Myers           504 BONE MARROW TRANSPLANT RECEPIENTS
                            ISOLATION AND PROPAGATION OF ALLOGENEIC CLINICAL GRADE T REGULATORY CELLS FOR GRAFT-
Chetan Dhamne           505 VERSUS-HOST-DISEASE
                            CYTOSINE ARABINOSIDE AND MITOXANTRONE FOLLOWED BY SECOND ALLOGENEIC STEM CELL
                            TRANSPLANTATION FOR THE TREATMENT OF CHILDREN WITH RELAPSED JUVENILE
Sachit Patel            506 MYELOMONOCYTIC LEUKEMIA (JMML)
Shivani Upadhyay        507 USE OF RAPAMYCIN IN A PATIENT WITH JMML - A CASE REPORT
                            A SINGLE CENTER EXPERIENCE USING MYELOABLATIVEA HEMATOPOIETIC STEM CELL
David Shyr              508 TRANSPLANTATION FOR β-THALASSEMIA AND SICKLE CELL DISEASE
Jessie Barnum           509 ENDOCRINE SEQUELAE OF STEM CELL TRANSPLANTATION
                            NOROVIRUS GASTROENTERITIS – AN EMERGING PATHOGEN IN PEDIATRIC HEMATOPOIETIC STEM
Parinda Mehta           510 CELL TRANSPLANT (HSCT) RECIPIENTS
                            USING SERUM FERRITIN AS A SCREENING TOOL FOR IRON DEFICIENCY IN THE ADOLESCENT FEMALE
Natasha Pillay Smiley   511 POPULATION
                            FETAL LOSS AMONG MOTHERS OF PATIENTS WITH INHERITED BONE MARROW FAILURE
Helen Reed              512 SYNDROMES
Amy Sobota              513 TRANSITION READINESS AMONG YOUNG ADULTS WITH SICKLE CELL DISEASE
Cathleen Cook           514 THE CLINICAL AND LABORATORY SPECTRUM OF HEMOGLOBIN C DISEASE
                            ANTI-D IMMUNOGLOBULIN THERAPY FOR PEDIATRIC ITP: THE EFFECT OF THE FDA'S BLACK BOX
Joel Thompson           515 WARNING
Sujata Mushrif          516 BACTEREMIA IN PATIENTS WITH SICKLE CELL DISEASE
                            ABSOLUTE LYMPHOCYTE COUNTS ARE USEFUL AS PREDICTORS OF PERSISTENT OR CHRONIC ITP IN
Michael Deel            517 CHILDREN
                            THE IMPACT OF EARLY TRANSFUSION IN THE MANAGEMENT OF SICKLE CELL PATIENTS WITH ACUTE
Abena Appiah-Kubi       518 CHEST SYNDROME (ACS)

Amma Owusu-Ansah        519 EXPLORING NRF2 AS A NOVEL THERAPEUTIC TARGET IN SICKLE CELL DISEASE:
                            COST OF CARE IN THALASSEMIA SYNDROMES: CHANGES OVER TIME RELATED TO EVOLVING
Drisana Henry           520 CHELATOR AVAILABILITY AND IRON MONITORING
                            INTRAVENOUS LOW MOLECULAR WEIGHT IRON DEXTRAN USE IN CHILDREN WITH IRON DEFICIENCY
Ellen Plummer           521 ANEMIA
                            TRANSFUSIONAL BURDEN IN LONG-TERM SURVIVORS OF CHILDHOOD HEMATOLOGIC
Kerri Nottage           522 MALIGNANCIES
                            HYDROXYUREA USE AND HOSPITALIZATION TRENDS IN A COMPREHENSIVE PEDIATRIC SICKLE CELL
Kerri Nottage           523 PROGRAM
                            INCREASED OXIDATIVE STRESS AND GENOMIC INSTABILITY IN PERIPHERAL BLOOD AND BONE
Kasiani Myers           524 MARROW OF INDIVIDUALS WITH FANCONI ANEMIA
Michael Kent            525 MICROPARTICLES: ROLE IN PACKED RED BLOOD CELL (PRBC) UNITS
Charise Freundlich      526 ACUTE CHEST SYNDROME: A CONTINUED CONCERN IN THE MODERN ERA
                            IMMUNE MARKERS OF DISEASE SEVERITY AND TREATMENT RESPONSE IN PEDIATRIC ACQUIRED
Kathryn Sutton          527 APLASTIC ANEMIA - A SINGLE INSTITUTION EXPERIENCE
                            RAPID RESPONSE OF DIARRHEA-ASSOCIATED HEMOLYTIC UREMIC SYNDROME (D+HUS) TO
Surbhi Saini            528 ECULIZUMAB ADMINISTRATION
                          ACCURATE CONTINUOUS ANTI-HEMOPHILIC FACTOR THERAPY (ACAT) SLIDING SCALE PROTOCOL
Jay Bryant-Wimp       529 EASES TRANSITION TO HOME
                          2011 REVISIONS TO THALASSEMIA CODING IN ICD-9 FAIL TO CAPTURE SALIENT DIFFERENCES IN
Drisana Henry         530 COST OF CARE FOR SYMPTOMATIC THALASSEMIA SYNDROMES
                          UNDERLYING IMMUNOLOGICAL DISORDERS, ANA POSITIVITY AND INFANCY PREDICTS
Ram Marwaha           531 UNFAVORABLE CLINICAL COURSE IN CHILDHOOD AUTOIMMUNE HEMOLYTIC ANEMIA
                          CASE OF RHODOCOCCUS EQUI BACTEREMIA AND CENTRAL LINE INFECTION IN AN
Jennifer Mullinax     532 IMMUNOCOMPETENT PEDIATRIC HEMOPHILIA PATIENT
                          INHERITED BLEEDING DISORDERS IN CHILDREN: A DECADE OLD EXPERIENCE FROM A TERTIARY CARE
Tanushree Sahoo       533 HOSPITAL IN NORTH-INDIA.
                          IRON DEFICIENCY ANEMIA ASSOCIATED WITH SEVERE AND PROLONGED LICE INFESTATION: A CASE
Omolade Oduala        534 REPORT
                          THERAPEUTIC TREATMENT WITH ANTI-D IMMUNE GLOBULIN FOR ITP: PREDICTING INDIVIDUAL
Jenny Despotovic      535 RESPONSES

Lauren Taylor         536 THROMBIN GENERATION AND PLATELET PROCOAGULANT ACTIVITY IN SEVERE HEMOPHILIA
                          SIROLIMUS FOR THE TREATMENT OF KAPOSIFORM HEMANGIOENDOTHELIOMAS/TUFTED
Adrienne Hammill      537 ANGIOMAS

Megan Doherty         538 TIMING OF RESOLUTION OF CENTRAL VENOUS LINE ASSOCIATED VENOUS THROMBO-EMBOLISM
                          CLINICAL FOLLOW UP OF SIX PATIENTS WITH COMPLICATED VASCULAR ANOMALIES TREATED WITH
Adrienne Hammill      539 SIROLIMUS
                          ROLE OF RACE/ETHNICITY ON IMMUNE TOLERANCE INDUCTION AND INHIBITOR RELAPSE IN
Glaivy Batsuli        540 CHILDREN WITH HEMOPHILIA A

Rosa Diaz             541 PREVALENCE OF BLEEDING DISORDERS IN ADOLESCENTS WITH HEAVY MENSTRUAL BLEEDING
                          UTILITY OF PLATELET FUNCTION ANALYZER AS A SCREENING TOOL FOR THE DIAGNOSIS OF VON
Swati Naik            542 WILLEBRAND DISEASE IN ADOLESCENTS WITH MENORRHAGIA
                          HEALTH-RELATED QUALITY OF LIFE (HRQOL) IN CHILDREN WITH NEWLY DIAGNOSED IMMUNE
Adolfo Flores         543 THROMBOCYTOPENIA: A STUDY FROM THE DALLAS ITP COHORT
Heather Mills         544 PLATELET FUNCTION DEFECTS IN ADOLESCENTS WITH MENORRHAGIA
                          RISK-STRATIFICATION OF PEDIATRIC INPATIENTS WITH INFLAMMATORY BOWEL DISEASE FOR
Cameron Trenor        545 PRIMARY VENOUS THROMBOPROPHYLAXIS
PRASANTH PILLAI       546 CONTRACEPTION-RELATED VENOUS THROMBOEMBOLISM IN A PEDIATRIC INSTITUTION
                          FAMILIAL THROMBOCYTHEMIA: A CASE REPORT OF THREE ARAB SIBLINGS WITH MPL GENE
Preethi Reddy Marri   547 MUTATION P.PRO106LEU AND ABNORMAL PLATELET AGGREGATION STUDIES.
                          A NOVEL MUTATION IN THE SERPINC1 GENE PRESENTING AS UNPROVOKED NEONATAL CEREBRAL
Riten Kumar           548 SINUS VENOUS THROMBOSIS IN A KINDRED.
                          CARDIOVASCULAR DISEASE RISK FACTORS AND RELATED EVENTS IN HOSPITALIZED ADULT AND
Ruchika Goel          549 PEDIATRIC PATIENTS WITH HEMOPHILIA

Ayesha Zia            550 THE UTILITY OF THROMBOELASTOGRAPHY AS A SCREENING TEST FOR BLEEDING DISORDERS
                          SUCCESSFUL TREATMENT OF ACQUIRED HEMOPHILIA A WITH RITUXIMAB IN A 5-YEAR-OLD GIRL
Matthew Fletcher      551 WITH INTESTINAL PERFORATION SECONDARY TO SMALL BOWEL OBSTRUCTION
                          CLINICAL EXPERIENCE WITH THE MEDICATION OF RECOMBINANT THROMBOMODULIN TO CHILDREN
Shinji Muto           552 WITH DIC IN JAPAN
                          ASSESSMENT OF MUSCULOSKELETAL FUNCTION AND MOOD IN HAEMOPHILIA A ADOLESCENTS: A
Sherif Badawy         553 CROSS-SECTIONAL STUDY
Allison Paroskie      554 ACQUIRED FACTOR XIII DEFICIENCY IN AN 18 YEAR OLD FEMALE
                          MONITORING OF THROMBIN GENERATION IN A PEDIATRIC PATIENT WITH ACQUIRED HEMOPHILIA
Surabhi Batra         555 A
                          PRESENTATION AND OUTCOME OF IDIOPATHIC THROMBOCYTOPENIC PURPURA: A SINGLE
Hamayun Imran         556 INSTITUTION EXPERIENCE
Abha Gupta            557 NEONATAL AORTIC THROMBOSIS: A CASE SERIES
                          ACQUIRED VON WILLEBRAND SYNDROME TYPE II-A IN A CHILD WITH RECURRENT LOWER
Payal Khincha         558 GASTROINTESTINAL BLEEDING POST FONTAN PROCEDURE
                          INTER-LABORATORY VARIABILITY IN MEASUREMENT OF FIBRINOGEN FOLLOWING PURIFIED
Emily Franzblau       559 FIBRINOGEN CONCENTRATE FOR DYSFIBRINOGENEMIA
Matthew Richardson     560 OBESITY IS NOT A RISK FOR PEDIATRIC VENOUS THROMBOSIS
                           CHARACTERIZATION OF GERMLINE TELOMERASE-ASSOCIATED GENE VARIANTS IN PEDIATRIC ACUTE
Maria Gramatges        561 MYELOID LEUKEMIA
                           HIGH RATE OF INFECTIOUS COMPLICATIONS AFTER RITUXIMAB TREATMENT IN A COHORT OF 3400
Marko Kavcic           562 CHILDREN TREATED AT CHILDREN’S HOSPITALS IN THE UNITED STATES

Jessica Heath          563 IRON DEPRIVATION IMPAIRS PROLIFERATION OF CALM-AF10 LEUKEMIA IN VITRO AND IN VIVO
                           REMISSION MARROW BLAST PERCENTAGE PREDICTS RELAPSE RISK IN CHILDREN WITH MYELOID
April Sorrell          564 LEUKEMIA ASSOCIATED WITH DOWN SYNDROME
                           PEDIATRIC CLINICAL TRIAL AND COMPASSIONATE USE EXPERIENCE WITH GLUCARPIDASE FOR
Scott Howard           565 METHOTREXATE TOXICITY

                           LEUKEMOGENIC WILMS TUMOR 1 MUTATIONS INCREASE PROLIFERATION THROUGH ABERRANT
Colleen Annesley       566 CELL CYCLE REGULATION, AND SYNERGIZE WITH FLT3/ITD MUTATIONS TO ENHANCE THESE EFFECTS

                           IN-HOSPITAL INDUCTION MORTALITY IN NATIONALLY REPRESENTATIVE COHORT OF 1763 CHILDREN
Marko Kavcic           567 TREATED FOR PEDIATRIC AML IN CHILDREN’S HOSPITALS IN THE UNITED STATES
                           EMOTIONAL AND BEHAVIORAL FUNCTIONING IN THE FIRST YEAR AFTER DIAGNOSIS OF STANDARD
                           RISK (SR) ACUTE LYMPHOBLASTIC LEUKEMIA (ALL): A REPORT FROM CHILDREN'S ONCOLOGY GROUP
Regina Myers           568 (COG) AALL0331
Nirali Shah            569 CD22 EXPRESSION IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA
                           FAMILY LIFE EVENTS IN THE FIRST YEAR AFTER DIAGNOSIS OF STANDARD RISK (SR) ACUTE
                           LYMPHOBLASTIC LEUKEMIA (ALL): A REPORT FROM CHILDREN’S ONCOLOGY GROUP (COG)
Samantha Lau           570 AALL0331

                             THE EFFICACY OF RASBURICASE DURING REDUCTION COP CHEMOTHERAPY FOR THE PREVENTION
                             OF TUMOR LYSIS SYNDROME (TLS) IN CHILDREN AND ADOLESCENTS WITH NEWLY DIAGNOSED
Jessica Hochberg       571   STAGE III/IV, BM+ AND CNS+ MATURE B-NHL: A CHILDREN’S ONCOLOGY GROUP REPORT
                             ENHANCING T CELL RECOVERY FOLLOWING INDUCTION CHEMOTHERAPY FOR ALL MAY IMPROVE
Catherine Boston       572   SURVIVAL: A ROLE FOR IMMUNE-MODULATORS
                             PREDICTORS OF SYMPTOMS AND SITE OF DEATH IN PEDIATRIC PALLIATIVE CANCER PATIENTS AT
Christina Schindera    573   END OF LIFE
                             ACUTE LYMPHOID LEUKEMIA CELLS WITH HIGHER ACTIVITY OF MATRIX METALLOPROTEINASES
Craig Mullen           574   EXHIBIT MORE AGGRESSIVE LEUKEMIA GROWTH IN VIVO
                             COMPARISON OF ALLERGIC REACTIONS BETWEEN INTRAVENOUS AND INTRAMUSCULAR
William Petersen       575   PEGASPARGASE ADMINISTRATION IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA
Nisha Rathore          576 PEDIATRIC HODGKIN LYMPHOMA: ARE WE OVER-SCANNING OUR PATIENTS?

                           THE HDAC INHIBITOR, ENTINOSTAT, POTENTIATES THE ACTIVITY OF IMATINIB AND DASATINIB IN
Rachel Rau             577 PHILADELPHIA CHROMOSOME POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA CELLS IN VITRO
                           GENETIC DETERMINANTS OF DISEASE RELAPSE AND THERAPY RELATED TOXICITY IN PEDIATRIC
Lisa Wray              578 ACUTE LYMPHOBLASTIC LEUKEMIA
                           CHILDREN WITH LEUKEMIA LACK IMPORTANT NATURAL KILLER CELL RECEPTOR-LIGAND
Erin Sullivan          579 INTERACTIONS TO CONTROL LEUKEMIC CLONES
                           INHIBITORS OF HISTONE DEACETYLATION AND DEMETHYLATION SYNERGIZE TO INDUCE CELL DEATH
Lorimar Ramirez        580 IN ACUTE LEUKEMIA CELLS
                           VARIABILITY IN ANTIBIOTIC USE FOR CHILDREN WITH ACUTE LYMPHOCYTIC LEUKEMIA ACROSS
Brian Fisher           581 UNITED STATES CHILDREN’S HOSPITALS

Anne Marsh             582 ARE BONE MARROW CORE BIOPSIES NECESSARY FOR THE INITIAL DIAGNOSIS OF ACUTE LEUKEMIA?

Rajkumar                   PULMONARY OUTCOMES FOLLOWING TREATMENT OF CHILDHOOD HODGKIN LYMPHOMA WITH
Venkatramani, MD, MS   583 CONTEMPORARY IRRADIATION
                           FAMILIAL HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS IN OMAN: FROM NON-EXISTENCE TO
Mohamed Elshinawy      584 MOLECULAR CHARACTERIZATION
                           CHILDHOOD PANCYTOPENIA WITHOUT CIRCULATING BLASTS: ETIOLOGIES AND PREDICTORS OF
Ghadir Sasa            585 DIAGNOSIS
Youmna Othman          586 REAL-TIME MECHANISTIC INTERROGATION OF T-CELL ALL (T-ALL) LEUKEMOGENESIS
                           TRANSAMINITIS ASSOCIATED WITH STEROID USE DURING INDUCTION PHASE OF MULTIPLE ALL
Mary Carroll           587 TREATMENT PROTOCOLS
Jeffrey Schwartz       588 OFF THERAPY VACCINE TITERS IN PEDIATRIC CANCER PATIENTS
                           INFLUENCE OF LENGTH OF TIME TO DIAGNOSIS AND TREATMENT ON THE SURVIVAL OF CHILDREN
Jillian Baker          589 WITH ACUTE LYMPHOBLASTIC LEUKEMIA: A POPULATION-BASED STUDY

Michael Angelo Huang   590 INVASIVE FUNGAL INFECTIONS IN CHILDREN WITH RELAPSED ACUTE LYMPHOBLASTIC LEUKEMIA

                           MAGNETIC RESONANCE IMAGING SPECTROSCOPY (MRS) AND BRAIN ATROPHY NORMALIZES
Nicolas Villanueva     591 FOLLOWING CHEMOTHERAPY IN PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)
Lisa Triche            592 BEXAROTENE IN A CHILD WITH PANNICULITIS-LIKE T-CELL LYMPHOMA
Jacqueline Halton      593 VITAMIN D STATUS IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA AT DIAGNOSIS
Nahal Rose Lalefar     594 IRON OVERLOAD IN CHILDHOOD CANCER
Alice Ruscica          595 TREATMENT OF HYPERLEUKOCYTOSIS; A SURVEY OF PEDIATRIC ONCOLOGISTS
                           ADRENAL INSUFFICIENCY AFTER INDUCTION CHEMOTHERAPY IN CHILDREN WITH ACUTE LYMPHOID
ADRIANA LINARES        596 LEUKEMIA.
                           A PILOT STUDY INVESTIGATING THE RELATIONSHIP BETWEEN DIET AND OXIDATIVE STRESS IN
Phillip Knouse         597 CHILDREN RECEIVING THERAPY FOR ACUTE LEUKEMIA.
                           SURVIVAL AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT) OR TYROSINE KINASE
                           INHIBITORS (TKI) IN CHILDREN WITH CHRONIC MYELOID LEUKEMIA(CML) IN CHRONIC PHASE;A
Nobuko Hijiya          598 SINGLE INSTITUTION EXPERIENCE
Sarah McKillop         599 MALE FERTILITY FOLLOWING DBVE/DBVE-PC FOR PEDIATRIC HODGKIN DISEASE
                           OUTCOME OF CHILDREN WITH LANGERHANS CELL HISTIOCYTOSIS III PROTOCOL: 5-YEARS’
Ram Marwaha            600 EXPERIENCE FROM CHANDIGARH, INDIA
                           SUCCESSFUL TREATMENT OF ASPERGILLUS ENDOCARDITIS AND BRAIN ABSCESSES IN A TEEN WITH
Ghada Abusin           601 RELAPSED ACUTE LYMPHOBLASTIC LEUKEMIA. CASE REPORT
                           ACTIVITY OF EXPANDED NATURAL KILLER CELLS AGAINST CHILDHOOD CANCERS USING THE
Anish Ray              602 PEDIATRIC PRECLINICAL TESTING PROGRAM IN VITRO CELL LINE PANEL
                           CLINICAL PRESENTATION AND MANAGEMENT OF SUBACUTE METHOTREXATE-INDUCED
Clara Lo               603 ENCEPHALOPATHY IN PATIENTS WITH PEDIATRIC MALIGNANCIES
                           ATTITUDES AND PRACTICES OF PROVIDERS REGARDING SCHOOL REINTEGRATION FOR CHILDREN
Sarah Leonard          604 WITH ACUTE LYMPHOBLASTIC LEUKEMIA
                           ACCURACY OF PHYSICAL EXAMINATION VERSUS ULTRASOUND IN THE DETECTION OF
Donna Johnston         605 HEPATOSPLENOMEGALY AT DIAGNOSIS OF PEDIATRIC LEUKEMIA

                           EIGHT COMMON MUTATIONS INTERPHASE-FISH PROBES FOR CHROMOSOME REARRANGEMENTS
Sakara Hutspardol      606 SCREENING IN PEDIATRIC B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA
Sadaf Altaf            607 ACUTE APPENDICITIS IN ACUTE LEUKEMIAS: A CASE SERIES AND LITERATURE REVIEW
David Gass             608 DECONSTRUCTING PEDIATRIC ACUTE LYMPHOCYTIC LEUKEMIA
                           THE USE OF NUCLEAR IMAGING TO EVALUATE CEREBROSPINAL FLUID (CSF) FLOW IN A PEDIATRIC
Caitlin Neri           609 LEUKEMIA PATIENT
                           UNUSUAL CLINICAL AND RADIOGRAPHIC INITIAL PRESENTATIONS OF A COMMON PEDIATRIC
Jorge Galvez           610 MALIGNANCY: LYMPHOMA.
Orren Beaty            611 ALTERED GROWTH HORMONE RESPONSE TO HYPOGLYCEMIA IN PRESENCE OF 6MP
                           SPECTRUM OF INFECTIONS WITH CENTRAL LINE CATHETERS IN CHILDREN WITH ACUTE LEUKEMIA :
MATHEW ZACHARIAH       612 A STUDY FROM OMAN
                           RESOLUTION OF THROMBOCYTOPENIA IN A PATIENT WITH T-CELL ACUTE LYMPHOBLASTIC
                           LEUKEMIA (ALL) FOLLOWING CHELATION THERAPY FOR TRANSFUSION-ASSOCIATED IRON
Kiranmye Reddy         613 OVERLOAD
Fae Majlessipour       614 CONSERVATIVE TREATMENT OF SYSTEMIC JUVENILE XANTHOGRANULOMA IN AN INFANT

                           MYELOID SARCOMA AND AML: MANAGEMENT CONTROVERSIES, REVIEW OF THE LITERATURE AND
Mireya Velasquez       615 FIRST DESCRIPTION OF A CHILD WITH MYELOID SARCOMA OF THE BLADDER

Andrea Dvorak          616 A CHILD WITH THREE DISTINCT HEMATOLOGIC MALIGNANCIES SPANNING OVER SIX YEARS
                           CHRONIC GRANULOMATOUS DISEASE DIAGNOSED IN AN INFANT WHOSE SIBLING DIED OF SERRATIA
Lauren Marcewicz       617 SEPSIS AND HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS
                           SIGNIFICANT CARDIAC IRON OVERLOAD IN AN 11-YEAR-OLD CHILD WITH ACUTE LYMPHOBLASTIC
Aaron Reitman          618 LEUKEMIA (ALL) AFTER ONLY ONE YEAR OF TREATMENT
                           CORTICOSTEROID-INDUCED GLAUCOMA AS A COMPLICATION OF INDUCTION THERAPY IN A CHILD
Kristy Pilbeam         619 WITH ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)
                           DIFFERENTIATION SYNDROME INDUCED BY ANESTHETIC AGENTS IN ACUTE PROMYELOCYTIC
Megha Kaushal          620 LEUKEMIA (APL)
Cathleen Cook          621 VITAMIN D DEFICIENCY AND HYPOCALCEMIA IN A NEWLY DIAGNOSED INFANT WITH AML

Hemalatha Rangarajan   622 SYSTEMIC EBV-POSITIVE T-CELL LYMPHOPROLIFERATIVE DISEASE OF CHILDHOOD: A CASE REPORT
                           SEQUENTIAL CHILDHOOD NEOPLASMS – LEUKEMIA FOLLOWING CENTRAL NERVOUS SYSTEM
Jeffrey Murray         623 TUMORS

Muaz Razzak            624 PLASMA CELL GRANULOMA (PCG) IN A CHILD WITH ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)
                           SUCCESSFUL TREATMENT OF RHINO-ORBITAL ZYGOMYCOSIS IN A TODDLER WITH ACUTE
                           LYMPHOBLASTIC LEUKEMIA WITH POSACONAZOLE IN COMBINATION WITH HYPERBARIC OXYGEN
Mohammed Almannai      625 THERAPY
                           LANGERHANS CELL HISTIOCYTOSIS - AN ORPHAN DISEASE: THE NATURAL HISTORY OF A SEVEN YEAR
Joanna Pierro          626 PERIOD OF UNDIAGNOSIS.
                           FACTORS INFLUENCING CENTRAL LINE INFECTIONS IN CHILDREN WITH ACUTE LEUKEMIA :A STUDY
MATHEW ZACHARIAH       627 FROM A SINGLE CENTER IN OMAN

Lorimar Ramirez        628 ROSAI –DORFMAN DISEASE PRESENTING AS A CEREBELLAR MASS IN A PEDIATRIC PATIENT
                           CLOSTRIDIUM SEPTICUM BACTEREMIA AND TYPHLITIS LEADING TO A RUPTURED APPENDIX IN A 7
Joseph Henderson       629 YEAR OLD WITH BURKITT'S LYMPHOMA
                           HODGKIN LYMPHOMA OF THE BONE MARROW WITHOUT LYMPHADENOPATHY AND UNUSUAL
Karen Fernandez        630 CYTOGENETIC TRANSLOCATION
                           MULTIDISCIPLINARY APPROACH TO REDUCTION OF CENTRAL LINE ASSOCIATED BLOOD STREAM
Amir Mian              631 INFECTIONS: AN INSTITUTIONAL EXPERIENCE WITH COLLOBORATIVE GUIDELINES
                           STREAMLINING THE CARE OF VASO-OCCLUSIVE EPISODES IN THE PEDIATRIC EMERGENCY
James Moses            632 DEPARTMENT: A QUALITY IMPROVEMENT INITIATIVE
Amy Billett            633 THE CHEMOTHERAPY HUDDLE: A STRATEGY TO MAXIMIZE PATIENT SAFETY
                           CHEMOTHERAPY MEDICATION ERRORS IN A PEDIATRIC CANCER TREATMENT CENTER: PROSPECTIVE
                           CHARACTERIZATION OF ERROR TYPES AND FREQUENCY AND DEVELOPMENT OF A QUALITY
Raymond Watts          634 IMPROVEMENT INITIATIVE TO LOWER THE ERROR RATE
                           PERSONALIZED REMINDER LETTERS INCREASE APPROPRIATE TRANSCRANIAL DOPPLER ULTRASOUND
John Strouse           635 (TCD) SCREENING IN CHILDREN WITH SICKLE CELL DISEASE

                           THE IMPACT OF IMPLEMENTATION OF ACCREDITATION COUNCIL FOR GRADUATE MEDICAL
                           EDUCATION (ACGME) 2011 RESIDENT DUTY HOUR REGULATIONS ON PEDIATRIC HEMATOLOGY-
Nicholas Fustino       636 ONCOLOGY (PHO) FELLOW CALL NIGHTS AT A TERTIARY CARE MEDICAL CENTER
                           BUILDING A NEW MODEL OF CLINICAL CARE: HOSPITALIST COVERAGE ON THE
Terrie Flatt           637 HEMATOLOGY/ONCOLOGY IN-PATIENT SERVICE
                           VARIABILITY IN CHEMOTHERAPY ORDERING PROCESSES AMONG HOSPITALS TREATING PEDIATRIC
Michael Jeng           638 ONCOLOGY PATIENTS

Timothy McCavit        639 DOES TIME-TO-ANTIBIOTICS PREDICT OUTCOME OF FEBRILE NEUTROPENIA IN PEDIATRIC CANCER?

                           SUCCESSFUL IMPLEMENTATION OF A MULTICENTER PEDIATRIC HEMATOLOGY/ONCOLOGY CENTRAL
Eric Werner            640 LINE ASSOCIATED BLOOD STREAM INFECTION COLLABORATIVE
                           CHANGING PEDIATRIC ONCOLOGY OUTCOMES IN LOW-INCOME COUNTRIES. FROM 23% TO 60%
Sandra Luna-Fineman    641 EFS IN 10 YEARS: GUATEMALA
                           THE PEDIATRIC HEMATOLOGY/ONCOLOGY EDUCATIONAL LABORATORY IN-TRAINING EXAMINATION
                           (PHOELIX): A NOVEL FORMATIVE EVALUATION OF LABORATORY SKILLS FOR CANADIAN PEDIATRIC
Elaine Leung           642 HEMATOLOGY/ONCOLOGY TRAINEES
                           DEVELOPMENTAL SCREENING OF INFANTS AND YOUNG CHILDREN WITH CANCER: A PILOT STUDY TO
Troy Quigg             643 IMPROVE QUALITY OF CARE

                           EVALUATION OF CENTRAL VENOUS CATHETER INFECTIONS IN FEBRILE, NON-NEUTROPENIC
Michael Jeng           644 PEDIATRIC ONCOLOGY PATIENTS WHO ARE NOT GIVEN EMPIRIC ANTIBIOTICS
                           CHEMOTHERAPY TREATMENT PLANS AND CONSENTS: A SINGLE INSTITUTION ANALYSIS OF
Amy Billett            645 AVAILABILITY AND CONTENT
                           DEVELOPMENT OF A THERAPEUTIC ALGORITHM TO GUIDE CLINICIANS CONSIDERING PALLIATIVE
Liza Johnson           646 SEDATION THERAPY IN PEDIATRIC PATIENTS AT THE END OF LIFE

Ionela Iacobas         647 POOR RESPONSE TO HEPATITIS B IMMUNIZATION IN CANCER PATIENTS PRIOR TO CHEMOTHERAPY
Jong Chung             648 UTILITY OF HEMATOLOGIC TESTING FOR CASES OF SUSPECTED NON-ACCIDENTAL TRAUMA

Anne Elliott           649 PALLIATIVE CARE EDUCATION: PRELIMINARY RESULTS OF A SURVEY OF PEDIATRIC ONCOLOGISTS
                           A TWINNING PROGRAM IN THE BORDER REGION: THE ST. JUDE- RADY CHILDREN'S HOSPITAL SAN
Paula Aristizabal      650 DIEGO APPROACH
                           ADEQUACY OF COMPLIANCE AND DOCUMENTATION WITH VACCINATION RECOMMENDATIONS IN
Andrew Freiberg        651 PEDIATRIC SICKLE CELL PATIENTS
                           SHOULD GNRH AGONISTS BE OFFERED TO YOUNG WOMEN WITH CANCER UNDERGOING
Paul Kent              652 CHEMOTHERAPY FOR FERTILITY PRESERVATION? AN ETHICAL DILEMMA.
                           VOCATIONAL PREPARATION AND EMPLOYMENT EXPERIENCES OF LONG-TERM SURVIVORS OF
Siddharth Karanth      653 CHILDHOOD CANCER: AN INITIAL, QUALITATIVE STUDY
Amy-Lee Bredlau        654 PHASE 1 STUDY OF ORAL KETAMINE FOR CHILDREN WITH CHRONIC PAIN
Eric Tai               655 HEALTH STATUS OF ADOLESCENT AND YOUNG ADULT CANCER SURVIVORS

                           KNOWLEDGE AND AWARENESS AMONG RESIDENTS REGARDING CANCER RISK FROM MEDICAL
Karen Fernandez        656 RADIATION EXPOSURE: A SINGLE UNIVERSITY TEACHING PROGRAM OBSERVATION

Jen-Yin Hou            657 ANALYSIS OF OUTCOME IN CANCER PATIENTS ADMITTED TO THE PEDIATRIC INTENSIVE CARE UNIT.
                           CLINICAL PRESENTATION AND DIAGNOSIS OF SPINAL CORD INVOLVEMENT OF MALIGNANCY IN
Jennifer Seelisch      658 CHILDREN
Kathleen                   BREAST CANCER AFTER CHEST RADIATION: ADEQUACY OF THE DOCUMENTATION OF RISK AND
Schwabenbauer          659 SCREENING INFORMATION GIVEN TO PATIENTS
                           UTILIZATION REVIEW OF EMERGENCY-RELEASE, UNCROSSMATCHED O NEGATIVE RED BLOOD CELLS
Jennifer Andrews       660 (RBCS) IN A TERTIARY CARE CHILDREN'S HOSPITAL
                           PROSPECTIVE EVALUATION OF THE NECESSITY OF MANUAL DIFFERENTIALS ON WHITE BLOOD CELL
Srikanth Ambati        661 COUNTS BELOW 500/MICROLITER IN A PEDIATRIC ONCOLOGY UNIT.
                           PEDIATRIC ONCOLOGISTS’ ASSESSMENT OF RESOURCES FOR NEW CANCER DIAGNOSIS
Jeremy Slone           662 EDUCATION

                           A META-ANALYSIS OF THE DIAGNOSTIC PERFORMANCE OF PROCALCITONIN IN THE DIAGNOSIS OF
Sarah Fitzgerald       663 SERIOUS BACTERIAL INFECTION IN PEDIATRIC FEBRILE NEUTROPENIA EPISODES
                           X-RAY SCREENING AND AVASCULAR NECROSIS OF FEMORAL HEAD IN CHILDREN AND ADOLESCENTS
Ram Kalpatthi          664 WITH SICKLE CELL DISEASE
                           ETHICAL ISSUES IN PEDIATRICS: TEN-YEARS OF CONSULT EXPERIENCE FROM A PEDIATRIC ACADEMIC
Liza Johnson           665 MEDICAL CENTER
                           PREVALENCE OF HEARING LOSS AMONG CHILDREN WITH CANCER AFTER RECEIVING
Alicia Bach            666 AMINOGLYCOSIDES
                           FATAL SICKLE CELL ASSOCIATED PULMONARY HYPERTENSION IN ADOLESCENTS: THREE CASES AND
Paul Kent              667 THE HIGHLIGHTED NEED OF SPECIALTY AND TRANSITIONAL CLINICS
                           MULTIPLE EPISODES OF PANCREATITIS DUE TO MERCAPTOPURINE AND NOT ASPARAGINASE
Chatchawin Assanasen   668 AFFECTING THERAPY IN PEDIATRIC LEUKEMIA
Kyle Jackson           669 PERCEPTIONS OF HEALTH AMONG PEDIATRIC HEMATOLOGY AND ONCOLOGY PATIENTS
                           SERUM GALACTOMANNA SCREENING FOR THE DIAGNOSIS OF INVASIVE PULMONARY
                           ASPERGILLOSIS (IPA) IN CHILDREN AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT)
Aharon Gefen           670 AND HIGH RISK LEUKEMIA
                           COMPARATIVE APPROACHES TO ADOLESCENT REFUSAL OF MEDICAL TREATMENT: UNITED
Regina Myers           671 KINGDOM (UK) AND UNITED STATES (USA)
Megan Ubinger          672 SCREENING FOR PSYCHOSOCIAL FUNCTIONING IN A PEDIATRIC SICKLE CELL POPULATION
                           IMPACT OF OSTEONECROSIS ON QUALITY OF LIFE IN SURVIVORS OF CHILDHOOD ACUTE
Carol Bruggers         673 LYMPHOBLASTIC LEUKEMIA
Cristina Fernandes     674 SEVERE TOXICITY AFTER VINCRISTINE (VCR) OVERDOSE: A CASE REPORT
Stephanie Olson        675 WHAT ARE THE TRUE RISKS OF SICKLE TRAIT?: AN ETHICAL DILEMMA
                             IMPACT OF LONG-TERM ERYTHROCYTAPHERESIS ON GROWTH AND PEAK HEIGHT VELOCITY OF
Abhishek Bavle           676 CHILDREN WITH SICKLE CELL DISEASE

Anthony Audino           677 THE HYPER-HEMOLYTIC PHENOTYPE OF SICKLE CELL DISEASE: DOES IT APPLY TO CHILDREN?
                             AMBULATORY AND MASKED HYPERTENSION ARE PREVALENT IN ASYMPTOMATIC CHILDREN WITH
Ram Kalpatthi            678 SICKLE CELL DISEASE

                             REDUCED TOXICITY CONDITIONING (RTC) AND ALLOGENEIC STEM CELL TRANSPLANTATION
                             (ALLOSCT) IN PEDIATRIC PATIENTS WITH HIGH-RISK SICKLE CELL DISEASE (SCD): ONE HUNDRED
Kavita Radhakrishnan     679 PERCENT EVENT-FREE SURVIVAL (EFS)/OVERALL SURVIVAL (OS) FOLLOWING SIBLING ALLOSCT
                             EFFECTS OF HYDROXYUREA ON GLOMERULAR HYYPERFILTRATION AND
Banu Aygun               680 MICROALBUMINURIA/PROTEINURIA IN CHILDREN WITH SICKLE CELL ANEMIA
                             PROPHYLACTIC PENICILLIN FOR CHILDREN WITH SICKLE CELL ANEMIA OVER 5 YEARS OF AGE: A
Megan Gilbert            681 NATIONAL SURVEY

Adrianna Vlachos         682 5Q- MYELODYSPLASTIC SYNDROME (MDS) MASQUERADING AS DIAMOND BLACKFAN ANEMIA (DBA)
                             PATIENT FACTORS ASSOCIATED WITH ABNORMAL LUNG FUNCTION IN CHILDREN WITH SICKLE CELL
Samuel Anim              683 DISEASE
                             PRACTICE PATTERNS OF STROKE SCREENING AND HYDROXYUREA USE IN CHILDREN WITH SICKLE
Gary Jones               684 CELL DISEASE: A SURVEY OF HEALTH CARE PROVIDERS

Michael Kent             685 HEMOGLOBIN GRAND JUNCTION: A NOVEL MUTATION ASSOCIATED WITH HEMOLYTIC ANEMIA

Susan Creary             686 PRODROMAL ILLNESS PRIOR TO ACUTE CHEST SYNDROME IN PEDIATRIC SICKLE CELL PATIENTS
                             AGE-RELATED IRON CHELATION UTILIZATION AND HEALTHCARE COSTS IN PATIENTS WITH SICKLE
Morey Blinder            687 CELL DISEASE (SCD)

                             CLINICAL PREDICTORS OF ALL-CAUSE IN-HOSPITAL MORTALITY IN PATIENTS WITH SICKLE CELL
Ruchika Goel             688 DISEASE (SCD) IN UNITED STATES: RESULTS FROM A NATIONALLY REPRESENTATIVE SAMPLE.
Gabrielle Paoletti       689 SEVERE IRON DEFICIENCY ANEMIA IN THE FIRST YEARS OF LIFE
                             IRON-CHELATING THERAPY (ICT) TREATMENT DISCONTINUATION, HOSPITALIZATION, AND COSTS IN
Medha Sasane             690 MEDICAID ENROLLEES WITH SICKLE CELL DISEASE (SCD) IN THE UNITED STATES
Jong Chung               691 INCREASING IRON OVERLOAD FOLLOWING SPLENECTOMY IN BETA THALASSEMIA MAJOR
                             RECOVERY OF NATIVE ERYTHROPOIETIN PRODUCTION IN A PATIENT WITH ERYTHROPOIETIN-
Mohamad Al-Rahawan       692 ASSOCIATED PURE RED CELL APLASIA
Michael Armstrong        693 MXI1 AND N-MYC INDUCE NEUROBLASTOMA CELL APOPTOSIS VIA DISTINCT PATHWAYS
                             ANTITUMOR EFFICACY OF THE INVESTIGATIONAL MEK INHIBITOR, TAK-733, AGAINST MELANOMA
Lindsey Micel            694 CELL LINES AND HUMAN-DERIVED TUMOR EXPLANT MODELS
Fiorela Hernandez        695 COMBINED AKT AND GLYCOLYSIS INHIBITION FOR THE TREATMENT OF NEUROBLASTOMA
Dennis Hughes            696 METADHERIN MEDIATES INVASION AND METASTASIS IN OSTEOSARCOMA

                             RENAL, HEPATIC AND INFECTIOUS COMPLICATIONS IN 2 DIFFERENT CONDITIONING REGIMENS
                             (BUSULFAN/MELPHALAN & CARBOPLATIN/ETOPOSIDE/MELPHALAN) FOR ADVANCED STAGE
Mahmoud Hammad           697 NEUROBLASTOMA: A COMPARISON OF THE CAIRO AND BOSTON EXPERIENCE
Elias Sayour             698 RNA NANOPARTICLE VACCINES TARGETING MEDULLOBLASTOMA
Sunil Bochare            699 STUDY OF HISTONE METHYLTRANSFERASE INHIBITORS IN PEDIATRIC BRAIN TUMORS

                             IMPROVING 3 AND 5 YEAR SURVIVAL OF DESMOPLASTIC SMALL ROUND CELL TUMOR IN CHILDREN,
Vivek Subbiah            700 ADOLESCENTS AND YOUNG ADULTS USING AGRESSIVE MULTI-MODAL STRATEGIES

Patrick Zweidler-McKay   701 LIGAND-MEDIATED CIS-INHIBITION: A NOVEL MECHANISM FOR NOTCH PATHWAY MODULATION
Anthony Audino           702 THE ROLE OF THE DELTA133 P53 ISOFORM IN EWING SARCOMA DEVELOPMENT
                             HER-4 EXPRESSION IN NEUROBLASTOMA CAUSES CHEMOTHERAPY- AND STRESS-RESISTANCE AND IS
Dennis Hughes            703 ASSOCIATED WITH WORSE SURVIVAL
                             THE ASSOCIATION BETWEEN THE C282Y HFE POLYMORPHISM AND ESTABLISHED ADVERSE
Michael Angelo Huang     704 PROGNOSTIC FACTORS IN CHILDHOOD NEUROBLASTOMA
                             A PILOT TRIAL OF THE NOVEL CHEMOTHERAPEUTIC REGIMEN OF TOPOTECAN, IFOSFAMIDE AND
                             CARBOPLATIN (TIC) IN CHILDREN AND ADOLESCENTS WITH REFRACTORY/RECURRENT SOLID
Kavita Radhakrishnan     705 TUMORS AND LYMPHOMAS
                             MORPHOPROTEOMIC PROFILING REVEALS MTOR AS THE PATHWAY OF CONVERGENCE IN
                             DESMOPLASTIC SMALL ROUND CELL TUMOR (EWS-WTI), EWING’S SARCOMA (EWS-FLI1) AND
Vivek Subbiah            706 WILMS TUMOR (WT1)

                               RIDAFOROLIMUS AS MAINTENANCE THERAPY IN ADVANCED SARCOMA PATIENTS FOLLOWING
                               CLINICAL BENEFIT FROM PRIOR CHEMOTHERAPY: PEDIATRIC DATA FROM THE PHASE 3 SARCOMA
Robert Iannone           707   MULTI-CENTER CLINICAL EVALUATION OF THE EFFICACY OF RIDAFOROLIMUS (SUCCEED) TRIAL
                               A 40-YEAR REVIEW OF PEDIATRIC LOW-GRADE GLIOMAS AT MAYO CLINIC: CHANGES WITH
Ryan Youland             708   MODERN IMAGING
                               UTILIZING THE T CELL RECEPTOR REPERTOIRE OF TUMOR INFILTRATING LYMPHOCYTES TO
Taizo Nakano             709   DEMONSTRATE CLONAL IMMUNE RESPONSES AGAINST PEDIATRIC SOLID TUMORS
                               ABERRANT HISTONE H1 LOCALIZATION IS A NOVEL RESPONSE BIOMARKER AND TARGET FOR
Patrick Zweidler-McKay   710   NEUROBLASTOMA
                               PRESENTATION CHARACTERISTICS AND TREATMENT OUTCOMES FOR EXTRACRANIAL MALIGNANT
                               GERM CELL TUMORS (MGCT): THREE YEARS OF EXPERIENCE AT SHAUKAT KHANUM CANCER
                               HOSPITAL (SKMCH&RC), LAHORE, PAKISTAN; AN INSTITUTION IN A DEVELOPING COUNTRY WITH
Haleema Saeed            711   LIMITED RESOURCES
                               DISPARITIES IN ACCRUAL TO INVESTIGATIONAL AGENT PROTOCOLS AMONG PEDIATRIC ONCOLOGY
Kelsey Johnson           712   PATIENTS
                               PRECLINICAL STUDIES OF SALINOMYCIN AS A THERAPEUTIC AGENT FOR GLIOMA CANCER STEM
Emily Moses              713   CELLS
                               NEURONATIN EXPRESSION SUPPRESSES CLONOGENICITY AND MAY AFFECT INTRACELLULAR
Haleema Saeed            714   CALCIUM HOMEOSTASIS IN HUMAN OSTEOSARCOMA CELLS
                               IS THERE A DIFFERENCE BY AGE IN TOXICITY IN PATIENTS TREATED WITH VINCRISTINE AND
Sadaf Altaf              715   CYCLOPHOSPHAMIDE FOR INTERMEDIATE RISK RHABDOMYOSARCOMA?
                               EXPRESSION OF EWS-FLI1 IN HUMAN MESENCHYMAL STEM CELLS VIA LENTIVIRAL TRANSDUCTION
Srikanth Ambati          716   REVEALS A CHARACTERISITIC GENETIC SIGNATURE
                               RETINOBLASTOMA (RB) PATIENTS WITH CHROMOSOME 13Q DELETIONS (13Q-) HAVE INCREASED
Rachel Brennan           717   CHEMOTHERAPY-RELATED TOXICITIES
                               AN EXPERIMENTAL APPROACH TO IDENTIFY EFFECTIVE TARGETS FOR NOVEL THERAPEUTIC AGENTS
Ronald Anderson          718   FOR PEDIATRIC MALIGNANT NEUROCUTANEOUS MELANOSIS (NCM)
Andres Morales           719 GENOME BASED OUTCOME PREDICTION IN HIGH RISK NEUROBLASTOMA
Shveta Gupta             720 TRANSITIONAL LIVER CELL TUMOR OF CHILDHOOD

                             A SINGLE INSTITUTION STUDY OF CHILDHOOD UNDIFFERENTIATED EMBRYONAL LIVER SARCOMA
Ashley Plant             721 (UELS): SUCCESS OF COMBINED THERAPY AND THE USE OF ORTHOTOPIC LIVER TRANSPLANT
Deepti Warad             722 THE INTERPLAY BETWEEN MONOCYTES AND TUMOR CELLS
                             LENGTH OF STAY AND TREATMENT-RELATED COMPLICATIONS SIMILAR IN PEDIATRIC AND AYA
Anthony Audino           723 SARCOMA PATIENTS IN U.S. CHILDREN'S HOSPITALS

                             SECONDARY MALIGNANT NEOPLASMS (SMN) AFTER INTENSIVE CHEMOTHERAPY AND TANDEM
Nobuko Hijiya            724 AUTOLOGOUS STEM CELL TRANSPLANTATION (ASCT) FOR HIGH-RISK NEUROBLASTOMA
Mark Applebaum           725 CLINICAL FEATURES AND OUTCOMES IN PATIENTS WITH SECONDARY EWING SARCOMA
Jennifer Aldrink         726 RENAL TUMORS IN CHILDREN AGE 5 YEARS AND OLDER
                             RISK OF TOXICITY, RELAPSE AND MORTALITY IN OVERWEIGHT AND UNDERWEIGHT CHILDREN WITH
Sadaf Altaf              727 OSTEOSARCOMA

Erin Karski              728 PATIENT CHARACTERISTICS AND OUTCOME IN EWING SARCOMA OVER 40 YEARS OLD AT DIAGNOSIS

Shivani Upadhyay         729 CRYPTOSPORIDIUM- AN UNLIKELY CULPRIT IN A SOLID TUMOR PATIENT WITH GASTROENTERITIS
Mark Ranalli             730 RENAL TUMORS IN CHILDREN YOUNGER THAN 12 MONTHS OF AGE

Derek Hanson             731 OUTPATIENT ADMINISTRATION OF COMPRESSED IFOSFAMIDE-ETOPOSIDE FOR SARCOMA PATIENTS
Erin Sullivan            732 CURE4KIDS IS FOR FELLOWS, TOO!

Bhakti Mehta             733 INFLAMMATORY MYOFIBROBLASTIC TUMORS: CHILDREN'S HOSPITAL LOS ANGELES EXPERIENCE
                             EXPRESSION OF UBIQUITIN CARBOXYL-TERMINAL HYDROLASE L1 (UCHL1) IN NEUROBLASTOMA
Aaron Sugalski           734 CANCER STEM CELLS AND ITS RELATIONSHIP TO PATIENT PROGNOSIS AND OUTCOME

Patrick Zweidler-McKay   735 A STUDY OF NEUROBLASTOMA PHENOTYPIC PLASTICITY
                             CONGENITAL NON-HEMANGIOMATOUS MALIGNANT MESENCHYMAL SCALP TUMORS:A SINGLE
Mariko Sato              736 INSTITUTIONAL EXPERIENCE
                             DOSE-LIMITING TOXICITY OF DOCETAXEL COMPLICATES ADDITIONAL THERAPY IN PATIENTS WITH
Violet Fernandes         737 LIMITED THERAPEUTIC OPTIONS

Aron Flagg               738 SYNCHRONOUS EBV-RELATED NASOPHARYNGEAL CARCINOMA AND HODGKIN LYMPHOMA
                             SUCCESSFUL IMPLEMENTATION OF A MODIFIED METHOTREXATE DESENSITIZATION PROTOCOL IN A
                             PATIENT WITH OSTEOSARCOMA AND ANAPHYLACTIC REACTION TO HIGH-DOSE METHOTREXATE
Abena Appiah-Kubi        739 (HDMTX)
                             NEAR COMPLETE RESPONSE TO NEOADJUVANT ETOPOSIDE-CISPLATIN REGIMEN IN UNRESECTABLE
Antonello Podda          740 PANCREATOBLASTOMA
                             THREE FOLD VARIATION IN DOSING CHEMOTHERAPY AGENTS IN INFANTS ACCORDING TO
Sadaf Altaf              741 CALCULATION METHOD

Santosh Upadhyaya        742 SINGLE AGENT BISPHOSPHONATE THERAPY IN MULTICENTRIC INFANTILE MYOFIBROMATOSIS
                             USE OF LOW-DOSE VINBLASTINE AND METHOTREXATE FOR LIFE-THREATENING SYSTEMIC INFANTILE
Alicia Lenzen            743 MYOFIBROMATOSIS
Nicholas Whipple         744 EXTRA-GONADAL FAMILIAL GERM CELL TUMORS IN TWO MALE CHILDREN

								
To top